Top 3 Health Care Stocks That May Explode In Q4
Top 3 Health Care Stocks That May Explode In Q4
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
在醫療保健板塊中，最被超賣的股票提供了一個投資於被低估公司的機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
相對強弱指數（RSI）是一個動量指標，它比較股票在價格上漲天數的強度與價格下跌天數的強度。與股票的價格走勢相比，它可以讓交易者更好地了解股票在開空期的表現。當RSI低於30時，通常認爲資產被超賣，依據Benzinga Pro的說法。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是該板塊中最新的主要被低估的股票名單，它們的RSI接近或低於30。
Silence Therapeutics PLC – ADR (NASDAQ:SLN)
Silence Therapeutics PLC – ADR (納斯達克:SLN)
- On Dec. 10, Chardan Capital analyst Keay Nakae maintained Silence Therapeutics with a Buy and maintained a $55 price target. The company's stock fell around 41% over the past month and has a 52-week low of $5.81.
- RSI Value: 26.72
- SLN Price Action: Shares of Silence Therapeutics fell 3.4% to close at $6.51 on Tuesday.
- Benzinga Pro's real-time newsfeed alerted to latest SLN news.
- 12月10日，Chardan Capital分析師Keay Nakae維持對Silence Therapeutics的買入評級，並設定55美元的目標價。該公司的股票在過去一個月內下跌了約41%，並且52周低點爲5.81美元。
- 相對強弱指標(RSI)值：26.72
- SLN價格動態：Silence Therapeutics的股票在週二下跌3.4%，收於6.51美元。
- Benzinga Pro的實時新聞提醒了最新的SLN資訊。
ModivCare Inc (NASDAQ:MODV)
ModivCare公司（納斯達克：MODV）
- On Nov. 6, ModivCare posted weaker-than-expected quarterly results. "This quarter has demonstrated positive momentum, reflected in both operational enhancements and strengthened relationships, even amid shifts in the broader healthcare market. We delivered solid third-quarter results, reporting $43 million of adjusted EBITDA and a 2% increase in consolidated revenue, driven primarily by 5% growth in our personal care services segment," stated L. Heath Sampson, President and CEO. The company's stock fell around 26% over the past five days and has a 52-week low of $11.00.
- RSI Value: 28.52
- MODV Price Action: Shares of ModivCare fell 11.4% to close at $14.10 on Tuesday.
- Benzinga Pro's charting tool helped identify the trend in MODV stock.
- 11月6日，ModivCare發佈了低於預期的季度業績。"本季度展示了積極的勢頭，反映在運營改進和增強的關係中，即使在更廣泛的醫療保健市場發生變化的情況下。我們交出了穩固的第三季度業績，報告調整後的EBITDA爲4300萬，以及營業收入增長2%，主要得益於個人護理服務板塊5%的增長，"L. Heath Sampson，總裁兼首席執行官表示。該公司的股票在過去五天內下跌了約26%，且52周最低爲11.00美元。
- 相對強弱指數（RSI）值：28.52
- MODV價格走勢：ModivCare的股票在週二收盤時下跌了11.4%，報14.10美元。
- Benzinga Pro的圖表工具幫助識別MODV股票的趨勢。
Olema Pharmaceuticals Inc (NASDAQ:OLMA)
Olema Pharmaceuticals公司（納斯達克：OLMA）
- On Dec. 10, Olema Oncology presented updated clinical results for Palazestrant in combination with Ribociclib at the San Antonio Breast Cancer Symposium. The company's stock fell around 37% over the past five days and has a 52-week low of $6.08.
- RSI Value: 23.69
- OLMA Price Action: Shares of Olema Pharmaceuticals fell 4.7% to close at $6.14 on Tuesday.
- Benzinga Pro's signals feature notified of a potential breakout in OLMA shares.
- 在12月10日，Olema Oncology在聖安東尼奧乳腺癌研討會上展示了Palazestrant與Ribociclib聯合使用的最新臨床結果。該公司的股票在過去五天內下跌了約37%，並且52周低點爲6.08美元。
- RSI值：23.69
- OLMA價格動態：Olema Pharmaceuticals的股票在週二下跌了4.7%，收盤價爲6.14美元。
- Benzinga Pro的信號功能通知OLMA股票可能會突破。
Read This Next:
接下來請閱讀：
- Top 2 Utilities Stocks That Could Sink Your Portfolio This Quarter
- 本季度可能會使您的投資組合下滑的前兩名公用事業股票
譯文內容由第三人軟體翻譯。
